Outline
DOI: 10.1200/jco.24.00162 ISSN: 0732-183X
Gaps in Access to Medically Necessary Dental Care for Patients Living With and Beyond Cancer: We Must Do Better
Douglas E. Peterson, Nicole L. Stout, Lawrence N. Shulman, Jennifer Perkins, Gabrielle LeMarier, Larissa Nekhlyudov- Cancer Research
- Oncology
Delivery of high-quality, evidence-based oral care for those living with and beyond cancer needed!
More from our Archive
- DOI: 10.1093/oncolo/oyae072 2024Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimensEddy Saad, Georges Gebrael, Karl Semaan, Marc Eid, Renée Maria Saliby, Chris Labaki, Nicolas Sayegh, J Connor Wells, Kosuke Takemura, Matthew Scott Ernst, Audreylie Lemelin, Naveen S Basappa, Lori A Wood, Thomas Powles, D Scott Ernst, Aly-Khan A Lalani, Neeraj Agarwal, Wanling Xie, Daniel Y C Heng, Toni K Choueiri
- DOI: 10.1093/oncolo/oyae060 2024Evolving assessment pathways for precision oncology medicines to improve patient access: a tumor-agnostic lensPriscila Radu, Gayathri Kumar, Amanda Cole, Aikaterini Fameli, Mark Guthrie, Lieven Annemans, Jan Geissler, Antoine Italiano, Brian O’Rourke, Entela Xoxi, Lotte Steuten
- DOI: 10.1158/2326-6066.cir-23-0926 2024Orchestrated codelivery of peptide antigen and adjuvant to antigen-presenting cells by using an engineered chimeric peptide enhances antitumor T-cell immunityHaifeng Pan, Siyuan Yu, Haoyun Zhuang, Han Yang, Jinlu Jiang, Haihui Yang, Shuling Ren, Guoxing Luo, Xuan Yu, Shuping Chen, Yanhua Lin, Roufang Sheng, Shiyin Zhang, Quan Yuan, Chenghao Huang, Tianying Zhang, Tingdong Li, Shengxiang Ge, Jun Zhang, Ningshao Xia
- DOI: 10.1158/2326-6066.cir-23-0757 2024Melanoma clonal heterogeneity leads to secondary resistance after adoptive cell therapy with tumor-infiltrating lymphocytesDavid König, Michael Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth A. Kappos, Dirk J. Schaefer, Christoph Kettelhack, Jakob R. Passweg, Andreas Holbro, Katharina Baur, Michael Medinger, Andreas Buser, Didier Lardinois, Lukas T. Jeker, Nina Khanna, Frank Stenner, Benjamin Kasenda, Krisztian Homicsko, Matthias Matter, Natalia Rodrigues Mantuano, Alfred Zippelius, Heinz Läubli
- DOI: 10.1200/jco.23.01708 2024Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell CarcinomaChristopher A. Barker, Suzanne Dufault, Sarah T. Arron, Alan L. Ho, Alain P. Algazi, Lara A. Dunn, Audrey A. Humphries, Carter Hultman, Ming Lian, P. Daniel Knott, Sue S. Yom
- DOI: 10.1200/jco.24.00162 2024Gaps in Access to Medically Necessary Dental Care for Patients Living With and Beyond Cancer: We Must Do BetterDouglas E. Peterson, Nicole L. Stout, Lawrence N. Shulman, Jennifer Perkins, Gabrielle LeMarier, Larissa Nekhlyudov
- DOI: 10.1093/carcin/bgae025 2024MIF/NR3C2 Axis Regulates Glucose Metabolism Reprogramming in Pancreatic Cancer through MAPK-ERK and AP-1 PathwaysShouhui Yang, Wei Tang, Azadeh Azizian, Jochen Gaedcke, Yuuki Ohara, Helen Cawley, Nader Hanna, B Michael Ghadimi, Trisha Lal, Subrata Sen, Chad J Creighton, Jianjun Gao, Nagireddy Putluri, Stefan Ambs, S Perwez Hussain
- DOI: 10.1093/oncolo/oyae071 2024Human malignancies associated with persistent HPV infectionAlison A McBride
- DOI: 10.1158/2326-6066.cir-23-0786 2024SIRT3 negatively regulates TFH cell differentiation in cancerYueru Hou, Yejin Cao, Ying He, Lin Dong, Longhao Zhao, Yingjie Dong, Ruiying Niu, Yujing Bi, Guangwei Liu
- DOI: 10.1002/cncr.35319 2024Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myelomaAttaya Suvannasankha, Nizar Bahlis, Suzanne Trudel, Katja Weisel, Christian Koenecke, Albert Oriol, Peter M. Voorhees, Aranzazu A. Alonso, Natalie S. Callander, María‐Victoria Mateos, Nishitha Reddy, Shawn Hakim, John LaMacchia, Nashita Patel, Danaé Williams, Roxanne. C. Jewell, Xiangdong Zhou, Ira Gupta, Joanna Opalinska, Ajay K. Nooka